Sort
48,018 grants matching “immunotherapy”
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology
$492,617Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology
$492,616Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2017 · CA
CD8+ T Cell Immunity to Cytomegalovirus
$492,596Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2010 · AI
Exploring the potential of TET inhibition in cancer immunotherapy
$492,576Anjana Rao · La Jolla Institute For Immunology · R01 · FY2023 · CA
Exploring the potential of TET inhibition in cancer immunotherapy
$492,576Anjana Rao · La Jolla Institute For Immunology · R01 · FY2022 · CA
Pro-tumorigenic functions of human DNA polymerases eta and kappa during genome duplication under physiological replication stress conditions
$492,572Kristin A Eckert · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA
Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation of Glioblastoma
$492,571Evan Charles Unger · Nuvox Pharma, Llc · R44 · FY2023 · CA
Immunoengineering Strategies for Musculoskeletal Trauma
$492,532Robert E Guldberg · University Of Oregon · R01 · FY2022 · AR
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$492,502William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
The role of plasmacytoid dendritic cells in corneal immunity
$492,500Pedram Hamrah · Schepens Eye Research Institute · R01 · FY2013 · EY
Defining a Protective Ebola Vaccine in Non-Human Primates
$492,487Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2016 · AI
Image-guided radiation-induced permeability (IGRIP) for IGDD
$492,442Stephen J. Kron · University Of Chicago · R01 · FY2017 · CA
A novel preclinical model of spontaneous metastasis
$492,427Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Neural and Immune Correlates of Painful Chemotherapy-Induced Neuropathy, Feasibility and Preliminary Efficacy of a Motor Cortex Non-Invasive Brain Stimulation Intervention
$492,420Timothy J Meeker · Morgan State University · U54 · FY2024 · MD
Virally-induced tumorigenesis controlled by the microbiota
$492,388Tatyana V. Golovkina · University Of Chicago · R01 · FY2019 · CA
INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES
$492,345John C Byrd · Ohio State University · P01 · FY2009 · CA
Establishment and regulation of the immune suppressive microenvironment in pancreatic cancer
$492,287Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.
$492,199Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
Dysregulated mechanoimmunology of epigenetics-driven lymphomas
$492,169Ankur Singh · Georgia Institute Of Technology · U01 · FY2024 · CA
Mechanisms of STING in malignant progression and therapy of CLL.
$492,142Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2025 · CA
Mechanisms of STING in malignant progression and therapy of CLL.
$492,142Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2023 · CA
CLINICAL TRANSLATION OF 19F MRI TO VISUALIZE CANCER IMMUNOTHERAPEUTIC CELLS
$492,130Eric T Ahrens · Carnegie-Mellon University · R01 · FY2011 · CA
Designing T cells to Functionally Cure HIV-1 infection
$492,087James L Riley · University Of Pennsylvania · U19 · FY2016 · AI
CLINICAL TRANSLATION OF 19F MRI TO VISUALIZE CANCER IMMUNOTHERAPEUTIC CELLS
$492,081Eric T Ahrens · Carnegie-Mellon University · R01 · FY2009 · CA
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
$492,054Ralph P Mason · Ut Southwestern Medical Center · R01 · FY2020 · CA